Hydroxyurea use after transitions of care among young adults with sickle cell disease and Tennessee medicaid insurance

Authors

Joacy G. Mathias, University of North Carolina at Chapel Hill
Vikki G. Nolan, The University of Memphis
Lisa M. Klesges, Washington University School of Medicine in St. Louis
Sherif M. Badawy, Ann & Robert H. Lurie Children’s Hospital of Chicago
William O. Cooper, Vanderbilt University
Jane S. Hankins, St Jude Children’s Research Hospital
Matthew P. Smeltzer, The University of Memphis

Journal

JAMA Network Open

Publication Date

2021

Volume

4

Issue

10

First Page

e2128971

Document Type

Open Access Publication

DOI

10.1001/jamanetworkopen.2021.28971

Rights and Permissions

Mathias JG, Nolan VG, Klesges LM, et al. Hydroxyurea Use After Transitions of Care Among Young Adults With Sickle Cell Disease and Tennessee Medicaid Insurance. JAMA Netw Open. 2021;4(10):e2128971. doi:10.1001/jamanetworkopen.2021.28971. This is an open access article distributed under the terms of the CC-BY License. © 2021 Mathias JG et al. JAMA Network Open.

Recommended Citation

Mathias, Joacy G.; Nolan, Vikki G.; Klesges, Lisa M.; Badawy, Sherif M.; Cooper, William O.; Hankins, Jane S.; and Smeltzer, Matthew P., "Hydroxyurea use after transitions of care among young adults with sickle cell disease and Tennessee medicaid insurance." JAMA Network Open. 4, 10. e2128971 (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10935